Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Short Interest Update

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) saw a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 116,700 shares, a decline of 33.2% from the January 15th total of 174,700 shares. Approximately 0.5% of the company’s shares are sold short. Based on an average daily volume of 70,300 shares, the short-interest ratio is presently 1.7 days.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Roth Mkm began coverage on Monogram Orthopaedics in a research report on Monday, December 9th. They issued a “buy” rating and a $4.00 price target on the stock. Roth Capital upgraded shares of Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Barclays PLC bought a new position in shares of Monogram Orthopaedics during the 3rd quarter valued at about $29,000. State Street Corp bought a new position in shares of Monogram Orthopaedics during the 3rd quarter valued at about $62,000. Geode Capital Management LLC boosted its holdings in shares of Monogram Orthopaedics by 1,267.4% during the 3rd quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock valued at $557,000 after purchasing an additional 194,776 shares during the last quarter. Jane Street Group LLC bought a new position in shares of Monogram Orthopaedics during the 4th quarter valued at about $25,000. Finally, Northern Trust Corp boosted its holdings in shares of Monogram Orthopaedics by 110.6% during the 4th quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock valued at $109,000 after purchasing an additional 24,088 shares during the last quarter. Institutional investors own 0.45% of the company’s stock.

Monogram Orthopaedics Trading Down 7.8 %

Monogram Orthopaedics stock traded down $0.21 during mid-day trading on Friday, hitting $2.48. The stock had a trading volume of 56,215 shares, compared to its average volume of 33,632. The firm has a market capitalization of $85.09 million, a P/E ratio of -5.28 and a beta of 1.55. The firm’s 50 day moving average is $2.63 and its 200 day moving average is $2.55. Monogram Orthopaedics has a one year low of $1.53 and a one year high of $4.90.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.